U.S., Dec. 13 -- ClinicalTrials.gov registry received information related to the study (NCT07278362) titled 'Testosterone Replacement Therapy in Hypogonadal Patients With Prostate Cancer Under Active Surveillance' on Dec. 04.
Brief Summary: The purpose of this study is evaluate the safety of testosterone replacement therapy in men with newly diagnosed low-risk prostate cancer and hypogonadism on active surveillance.
Study Start Date: Feb., 2026
Study Type: INTERVENTIONAL
Condition:
Prostate Cancer
Hypogonadism, Male
Intervention:
DRUG: Testosterone cypionate
Participants will self-inject 100mg of testosterone cypionate once per week for 12 months
Recruitment Status: NOT_YET_RECRUITING
Sponsor: University of Miami
Information prov...